Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Interventional × Engineering × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 1

Interventions

Cisplatin 106 Carboplatin 104 Drug Therapy 92 Oxaliplatin 90 Capecitabine 82 Bevacizumab 79 Paclitaxel 77 pembrolizumab 75 Cyclophosphamide 74 Gemcitabine 73 Radiotherapy 71 tislelizumab 68 Specimen Handling 56 Fluorouracil 55 toripalimab 54 Injections 49 Docetaxel 48 sintilimab 47 Magnetic Resonance Spectroscopy 45 130-nm albumin-bound paclitaxel 44 Surgical Procedures, Operative 42 Leucovorin 39 Pemetrexed 37 fludarabine 36 anlotinib 36 Biopsy 36 Radiosurgery 35 Standard of Care 34 lenvatinib 33 Irinotecan 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07366658 2026-01-26

NEUK203-13

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 1 Not yet recruiting

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡